U-96988
U-96988 (PNU-96988) is a non-peptide HIV-1 protease inhibitor with a Ki value of 38 nM. U-96988 is also effective against HIV-2 protease. U-96988 exhibits an IC50 for HIV-1IIIB of 5 μM. U-96988 can be used for research on HIV infection.
For research use only. We do not sell to patients.
- CAS No.: 149394-65-0
- Formula: C24H26O3
- Molecular Weight:362.46
-
Storage:
Please store the product under the recommended conditions in the Certificate of Analysis.
Biological Activity
Description
Cellular Effect
|
Cell Line
|
Type | Value | Description | References |
|---|---|---|---|---|
| H9 | ED50 |
3 μM
Compound: 7
|
Tested for the antiviral activity against HIV-1 IIIB-infected H9 cells
Tested for the antiviral activity against HIV-1 IIIB-infected H9 cells
|
[PMID: 7932546] |
| MT4 | ED50 |
3 μM
Compound: 7
|
Tested for the antiviral activity against HIV-1 IIIB-infected MT-4
Tested for the antiviral activity against HIV-1 IIIB-infected MT-4
|
[PMID: 7932546] |
Chemical Information
-
CAS No. 149394-65-0
-
Molecular Weight 362.46
-
Formula C24H26O3
-
SMILES
O=C1C(C(C2=CC=CC=C2)CC)=C(O)C=C(C(CC3=CC=CC=C3)CC)O1
-
Synonyms
PNU-96988
-
Shipping
Room temperature in continental US; may vary elsewhere.
-
Storage
Please store the product under the recommended conditions in the Certificate of Analysis.
Protocols
-
Research Protocol for Infectious Diseases
Infectious-disease experiments test how pathogens interact with host barriers, innate immune receptors, inflammatory signaling, pathogen replication, and tissue injury; pattern-recognition receptors such as TLRs, RIG-I-like receptors, NOD-like receptors, and inflammasomes detect microbial molecules and activate NF-κB, interferon, and cytokine responses. The central hypothesis is that infection severity reflects the balance between pathogen burden and host response: protective inflammation restricts pathogen growth, whereas excessive or mislocalized inflammation contributes to tissue damage and disease phenotype. Unresolved questions include which host pathways are protective versus pathogenic, why some infection models fail to translate to human disease, and which combined readouts best predict clinically relevant infection outcomes.
-
Cell Cytotoxicity Assay
Cytotoxicity assays are usually based on the assessment of cell membrane damage, which can also be indirectly detected by measuring cell viability. Detection methods include MTT assay, CKK-8 assay, LDH assay and ATP assay, etc.
Purity & Documentation
References
[1]. Koeplinger KA, et al. Equilibrium distribution of HIV antiviral drugs into human peripheral blood mononuclear cells (PBMC) is controlled by free drug concentration in the extracellular medium. J Pharm Biomed Anal. 1999 Mar;19(3-4):399-411. [Content Brief]
[2]. Thaisrivongs S, et al. Structure-based design of HIV protease inhibitors: 5,6-dihydro-4-hydroxy-2-pyrones as effective, nonpeptidic inhibitors. J Med Chem. 1996 Nov 8;39(23):4630-42. [Content Brief]
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)